Bartter syndrome: benefits and side effects of long-term treatment (Q44943287)

7 December 2017

title

Bartter syndrome: benefits and side effects of long-term treatment (English)

1 reference

7 December 2017

author name string

Maria Helena Vaisbich

series ordinal

1

1 reference

7 December 2017

Maria Danisi Fujimura

series ordinal

2

1 reference

7 December 2017

Vera H Koch

series ordinal

3

1 reference

7 December 2017

publication date

16 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

8

1 reference

7 December 2017

page(s)

858-863

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-004-1527-8

7 December 2017

exact match

0 references

cites work

Functional Characterization of a Calcium-Sensing Receptor Mutation in Severe Autosomal Dominant Hypocalcemia with a Bartter-Like Syndrome

1 reference

12 December 2020

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK

1 reference

12 December 2020

Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III

1 reference

12 December 2020

Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome

1 reference

12 December 2020

The neonatal variant of Bartter syndrome and deafness: preservation of renal function

1 reference

12 December 2020

Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

1 reference

12 December 2020

Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter???s syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib

1 reference

12 December 2020

Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter

1 reference

12 December 2020

Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors

1 reference

12 December 2020

Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2

1 reference

12 December 2020

Bartter's syndrome. A review of 28 patients followed for 10 years

1 reference

12 December 2020

Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy

1 reference

12 December 2020

Correction of hypokalemia in Bartter's syndrome by enalapril

1 reference

12 December 2020

Genotype/phenotype observations in African Americans with Bartter syndrome

1 reference

12 December 2020

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

1 reference

12 December 2020

Association between activating mutations of calcium-sensing receptor and Bartter's syndrome

1 reference

12 December 2020

Hypokalaemic salt-losing tubulopathies: an evolving story

1 reference

12 December 2020

Bartter syndrome: unraveling the pathophysiologic enigma

1 reference

12 December 2020

Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness

1 reference

12 December 2020

1 reference

12 December 2020

[A patients with chronic renal failure due to Bartter's syndrome]

1 reference

12 December 2020

10.1007/S00467-004-1527-8

Identifiers

DOI

1 reference

7 December 2017

1 reference